/

Empresas

el

No verificado

eleva GmbH

Sobre qué escribimos

Anuncios brevesBiotecnologíaMedicina Salud Bienestar

3 Comunicados de prensa

Ver todos los comunicados de prensa

20/10/2025

Biotecnología

Medicina Salud Bienestar

Anuncios breves

Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers

Fuente

Editor

1.00

0

06/07/2025

Biotecnología

Anuncios breves

Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers

Fuente

Editor

1.00

0

12/05/2025

Biotecnología

Anuncios breves

Eleva Appoints Donato Spota as Chief Financial Officer

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0